Evaluate Risks Before Recommending a Flozin

November 2018

New safety concerns will raise questions about when to use an SGLT2 inhibitor (Invokana, etc) for type 2 diabetes.

Flozins are in the spotlight lately...since some may have cardiovascular and renal benefits.

But we know flozins have risks...yeast infections, UTIs, hypotension, acute kidney injury, rare ketoacidosis or fractures, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Aspirin Think Twice About Low-Dose Aspirin to Prevent Cardiovascular Disease
E-Cigarettes Talk to Kids About the Harms of E-Cigs and Vaping
Osteoporosis Identify Patients at Risk for Fractures Due to Chronic Steroids
Pregnancy Expect Med Changes in Pregnant Women With Thyroid Disease
Men's Health Clarify the Role of Antibiotics for Prostatitis
Endocarditis Emphasize Adherence in Endocarditis Patients on Oral Antibiotics
Vaccines Recommend Shingrix Instead of Zostavax II for Most Patients
Diabetes Meds Evaluate Risks Before Recommending a Flozin
Dermatology Focus on Proper Application of Antiperspirants for Profuse Sweating
Pediatrics Explain Risks and Benefits of Breastfeeding to Mothers on Methadone
Practice Combat Counterfeit Meds
Communication Personalize Care for Millennial Patients